Captor Therapeutics SA
F:60Q
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Captor Therapeutics SA
F:60Q
|
PL |
|
Cashbuild Ltd
OTC:CBLDF
|
ZA |
|
F
|
Fairfax Financial Holdings Ltd
SWB:FFX
|
CA |
|
B
|
BCE Inc
XMUN:BCE1
|
CA |
|
Duerr AG
F:DUE
|
DE |
|
H
|
Hon Hai Precision Industry Co Ltd
F:HHP2
|
TW |
|
R
|
Radian Group Inc
XBER:RAG
|
US |
|
Spire Global Inc
F:43J
|
US |
|
R
|
Ryanair Holdings PLC
XBER:RY4C
|
IE |
|
N
|
Nasdaq Inc
DUS:NAQ
|
US |
|
M
|
Masco Corp
SWB:MSQ
|
US |
Intrinsic Value
The intrinsic value for Captor Therapeutics SA (60Q) under the Base Case is hidden EUR. Compared with the current market price of 18.02 EUR, the stock appears hidden .
60Q looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether 60Q usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Captor Therapeutics SA.
The intrinsic value for Captor Therapeutics SA (60Q) under the Base Case is hidden EUR.
Compared with the current market price of 18.02 EUR, the stock appears hidden.